FDA Approves New Drug for Psoriatic Arthritis

In a statement released on March 21, 2014, the U.S Food and Drug Administration announced that the FDA approved a new drug to treat adults with active psoriatic arthritis (PsA). The new drug is “Otezla”, and Bill Berkot, in “Update 2- U.S.

FDA Approves New Drug for Tinea Corporis

The FDA recently approved a new drug application to treat tinea corporis, tinea cruris, and tinea pedis. The drug is luliconazole, a topical azole antifungal cream.

Luliconazole is approved for a 1-week, once-daily treatment regimen treatment course in adults over 18 years old with tinea corporis or tinea cruris. Treatment for interdigital tinea pedis is once daily for 2 weeks. 

Product Theater- Sponsored by Valeant - Imiquimod 5% cream - Dr. Batiav

This podcast is on the use of Imiquimod 5% cream with Dr. Batiav and was recorded at the 2013 Summer SDPA Conference in St. Louis.

Australia Bans Tanning Beds Nationally

Australia, home of some of the highest skin-cancer rates in the world, recently announced a complete ban on tanning beds. Skin cancer led to 2,000 deaths in 2011 in Australia and is responsible for 80% of all new cancer cases diagnosed each year. In light of these statistics, five of Australia’s eight states and territories plan on completely banning tanning beds by 2015; New South Wales is implementing the ban at the end of the year.

Syndicate content
Copyright © 2013 by SDPA - All Rights Reserved